ขาย 3,704 5,180 -28% 4,236 -13% 12,571 14,253 -12% EBITDA 289 211 37% 137 111% 637 750 -15% อตัรากําไร EBITDA (%) 7.8% 4.1% 3.7% 3.2% 4.6% 5.1% 5.3% -0.2% Stock Gain/(Loss) & NRV -57 -143 -60% -149 -62

units relating to operational function, compliance function, internal audit or risk management; (4) managing investment in capital market products, financial instruments or other specified assets; (5

Dec 14 31 Dec 15 31 Dec 16 Income From Sales 1,111.63 1,294.32 1,454.45 Sales Expanses (1,021.30) (1,121.42) (1,262.34) Gross Profit 90.33 172.90 192.11 Other Income 4.48 1.78 4.66 Profit before

percent of the total shares of NEXT, from the Seller. The Company shall pay for the share acquisition upon a condition that the payment amount is varied according to the calculation from the earnings before

earnings before interest and taxes (EBIT) based on NEXT’s operating performance reported in the audited financial statements for the year ended December 31, 2 0 2 0 (the “Financial Statement”), and the

396 15% 11% Net profit 2,822 2,530 2,847 1% 13% Excluding non-recurring items 2,822 2,545 2,902 3% 14% Earnings per basic share (THB) 0.63 0.56 0.63 1% 13% Excluding non-recurring items 0.63 0.57 0.65 3

148.63 148.63 148.63 Total Revenue 2,963.84 2,917.86 1,410.83 Net Profit 315.10 305.90 154.30 Earnings Per Share (EPS) 0.53 0.51 0.26 Key Financial Ratios ROA (%) 22.05 21.20 n.a. ROE (%) 49.67 44.66 n.a

ลงเนื่องจำกอุปสงค์และอุปทำนของอุตสำหกรรมไบโอดีเซลปรับเข้ำสู่สมดุล มำกขึ้น อย่ำงไรก็ตำม บริษัทฯ ได้รับผลกระทบของ Stock Gain & NRV จ ำนวน 92 ล้ำนบำท เมื่อหักผลกระทบดังกล่ำว ท ำให้ บริษัทฯ มี Adjusted

-6% 9,213 12,571 -27% EBITDA 44 289 -85% 88 -50% 273 637 -57% อัตราก้าไร EBITDA (%) 1.4% 7.8% -6.4% 2.7% -1.3% 3.0% 5.1% -2.1% Stock Gain/(Loss) & NRV 13 -57 -123% -58 -122% -119 -439 -73% Adjusted

subsidiaries, where subsidiaries whose absolute net assets, net liabilities or profit or loss before tax accounts for 10% or more of those of the group for any of the two most recent completed financial years or